$rVRXA
Veraxa Biotech is a Switzerland-based, pre-clinical and early clinical-stage biopharmaceutical company leveraging its proprietary BiTAC platform and high-throughput single-cell screening system to develop next-generation bispecific T-cell engagers (TCEs) and antibody-drug conjugates (ADCs) for solid and hematological tumors.
$0.00
0
$0.00
Veraxa Biotech AG Bitget Metrics
Metric
Show % of Total
Key Facts
Name
Veraxa Biotech AG Bitget
Ticker
rVRXA
CUSIP
—
ISIN
—
Platform
—
Tokenization Type
Type
—
Manager
—
Asset Class
Underlying Assets
—
Eligible Investors
Inception Date
01/01/2026
Use Of Income
—
Management Fees
0%
Performance Fees
0%
Market Data
Total Value
—
NAV
—
Price
—
Token Supply
2.00
△
Circulating Supply
2.00
△
7D APY
—
30D APY
—
Holders
—
Trailing 30D Active Addresses
—
Monthly Transfer Count
0
△
Monthly Transfer Volume
$0
△
Tokens
Primary Market
Eligible Investors
Non-U.S. Investor
Base Assets
USDCUSDT
Subscription Time
Instant
Min. Investment
20 USDC
Subscription Fees
0.10%
Subscription Description
—
Redemption Time
Instant
Minimum Redemption Amount
0 USDC
Redemption Fees
0.10%
Redemption Description
—
KYC Description
—
Service Providers
Platform
—
Manager
—
Sub-Advisor
—
Custodian
Legal Identifier
—
Crypto Custodian
—
Fund Administrator
—
Traditional Broker
—
Crypto Broker
—
Auditor
—
Transfer Agent
—
Paying Agent
—
Legal & Regulatory
Issuer
BG El Salvador
Issuer LEI
—
Issuer CIK
—
Domicile
El Salvador
Regulatory Framework
El Salvador Digital Asset Law (LEAD), U.S. Securities Act Reg. S Exemption
Dispute Resolution Country
—
Account Segregation
—
Bankruptcy Remote
—
Deposit Insurance
—
Terms
—
Fees
Management Fees
0%
Performance Fees
0%
Other Fees
—
Redemption Fees
0.10%
Subscription Fees
0.10%
RWA.xyzAll Rights Reserved